calendar
5,159 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 256 earnings · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
5,159 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 256 earnings · 2 approval · 1 adcom
Sponsor: Ottawa Heart Institute Research Corporation. Phase: PHASE3. Conditions: Pericarditis
Sponsor: Cardiol Therapeutics Inc.. Phase: PHASE2. Conditions: COVID-19, Cardiovascular Diseases, Cardiovascular Risk Factor
Sponsor: Ankara Medipol University. Phase: . Conditions: Patellofemoral Pain, PFP
Sponsor: City of Hope Medical Center. Phase: PHASE2. Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma
Sponsor: Brown University. Phase: NA. Conditions: Smoking Cessation, Obesity and Obesity-related Medical Conditions
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Vestibular Diseases
Sponsor: Chongqing University Cancer Hospital. Phase: PHASE2. Conditions: Rectal Neoplasms, Rectal Adenocarcinoma
Sponsor: Addis Ababa University. Phase: NA. Conditions: Breast Neoplasms, Musculoskeletal Pain, Arthralgia, Musculoskeletal Diseases, Pain, Fatigue Syndrome, Chronic
Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Metastatic Sarcoma, Recurrent Sarcoma, Resectable Sarcoma
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Healthy Control
Sponsor: Johnson & Johnson Enterprise Innovation Inc.. Phase: PHASE1. Conditions: Neoplasms
Sponsor: Takeda. Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer
Sponsor: Kazuya Hosokawa. Phase: PHASE4. Conditions: Eisenmenger Syndrome, Pulmonary Arterial Hypertension of Congenital Heart Disease
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive, CD5 Positive, FCER2 Negative, Pleomorphic Variant Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma, t(11;14)(q13;q32)
Sponsor: Yan Fuxia. Phase: . Conditions: Delirium - Postoperative, Sleep Problems
Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia. Phase: PHASE2. Conditions: HIV
Sponsor: Hawaii Pacific Health. Phase: NA. Conditions: Induction of Labor Affected Fetus / Newborn
Sponsor: Dana-Farber Cancer Institute. Phase: PHASE2. Conditions: SDH Gene Mutation, Gastrointestinal Stromal Tumor
Sponsor: InSightec. Phase: NA. Conditions: Parkinsons Disease
Sponsor: Centro de Edafología y Biología Aplicada del Segura. Phase: NA. Conditions: Prediabetes
Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Bronchopulmonary Dysplasia, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Extreme Prematurity, Ventilator Lung; Newborn, Ventilation Perfusion Mismatch
Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Pectus Excavatum, Pain, Postoperative
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre. Phase: . Conditions: Apnea of Prematurity, Preterm Infant, Periodic Breathing, Hypopnea
Sponsor: University Medical Centre Ljubljana. Phase: PHASE3. Conditions: Tick-Borne Encephalitis
Sponsor: Mayo Clinic. Phase: . Conditions: Healthy, Congenital Heart Disease
Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: HIV Infections, Syphilis Infection
Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Neoplasms
Sponsor: Brigham and Women's Hospital. Phase: PHASE1. Conditions: Low Back Pain
Sponsor: Aragon Pharmaceuticals, Inc.. Phase: PHASE1. Conditions: Prostatic Neoplasms, Castration-Resistant
Sponsor: Igdir University. Phase: NA. Conditions: Chest Tube Removal
Sponsor: Ankara Yildirim Beyazıt University. Phase: NA. Conditions: Pediatric Intensive Care Unit, Comfort, Anxiety in Children, Fear, Sleep
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Evaluable
Sponsor: California Pacific Medical Center Research Institute. Phase: . Conditions: Gastrointestinal Neoplasms, Benign Neoplasm of Intestinal Tract
Sponsor: Celal Bayar University. Phase: . Conditions: Preterm Premature Rupture of Membrane, Placenta Diseases
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Phase: . Conditions: Acute Kidney Injury
Sponsor: Huahui Health. Phase: PHASE2. Conditions: Chronic Hepatitis B Virus Infection
Sponsor: Martin Blomberg Jensen. Phase: PHASE1. Conditions: Infertility Due to Azoospermia, Infertility, Male
Sponsor: Hospital de Clinicas de Porto Alegre. Phase: NA. Conditions: Fibromyalgia
Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Neoplasms, Cancer
Sponsor: Ottawa Heart Institute Research Corporation. Phase: NA. Conditions: Cardioversion, Atrial Fibrillation
Sponsor: University of California, San Francisco. Phase: . Conditions: Melanoma, Advanced Melanoma
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Primary Sclerosing Cholangitis
Sponsor: AstraZeneca. Phase: . Conditions: Non-cystic Fibrosis Bronchiectasis
Sponsor: Nabil Adra. Phase: PHASE2. Conditions: Germ Cell Tumor, Non-seminomatous Germ Cell Tumor, Ovarian Germ Cell Tumor
Sponsor: Alcon Research. Phase: NA. Conditions: Aphakia
Sponsor: Necmettin Erbakan University. Phase: . Conditions: Metastatic NSCLC - Non-Small Cell Lung Cancer
Sponsor: Duke University. Phase: NA. Conditions: Coronary Heart Disease Risk
Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Pulmonary Thromboendarterectomy, Pulmonary Embolism and Thrombosis
Sponsor: University College, London. Phase: NA. Conditions: HIV Prevention, Contraceptive Usage, Adherence, Medication
Sponsor: Huahui Health. Phase: PHASE3. Conditions: Chronic Hepatitis D Infection